Humanized antibodies against TL1A

Details for Australian Patent Application No. 2008320987 (hide)

Owner Teva Biopharmaceuticals USA, Inc.

Inventors Rosen, Craig; Smith, Rodger; Roschke, Viktor; Kanakaraj, Palanisamy; Cooksey, Bridget A.

Agent Griffith Hack

Pub. Number AU-A-2008320987

PCT Pub. Number WO2009/064854

Priority 60/987,651 13.11.07 US

Filing date 13 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/064854 Priority application(s): WO2009/064854

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320991-Cochlear implant stimulation artifacts

2008320980-Porous containment device and associated method for stabilization of vertebral compression fractures